Document is current

Article History

Accepted: 21 August 2022

First Online: 15 September 2022

Declarations

:

: This research received no grant from any funding agency in the public, commercial, or not-for-profit sectors. YolaRX Consultants funded the open access.

: All authors are employees of YolaRX Consultants, a research organization that provides consultancy services to pharmaceutical companies on topics unrelated to the work presented in this article.

: This study used existing anonymous data and thus no ethics approval was required.

: Not applicable.

: Not applicable.

: The data that support the findings of this study are not publicly available because of a data-sharing agreement with the data custodians.

: The code produced for the data analyses is not publicly available.

: YM and AMC contributed to the concept and design of the study as well as to the acquisition of the data. AMC conducted all data management activities and produced all statistical analyses. All authors developed and revised the manuscript for important intellectual content, approved the final version for publication, and agreed to be accountable for the work. YM was the principal investigator and supervised all components of the study.